Table 4 Summary of thermal degradation assessments of candidate standards HPV6, 11, 31, 33, 45, 52 and 58 tested by reference laboratories REF-1 and REF-2 using PBNA and antibody-binding methods
From: WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58
 | Predicted loss per year at −20 °C | ||||
---|---|---|---|---|---|
Candidate Standard | Time at elevated temperatures (years) | REF-1 (PBNA) | REF-2 (PBNA) | REF-1 (Ab-Binding) | REF-2 (Ab-Binding) |
HPV6 | 1.14 | * | < 0.001% | 5.23%** | 0.02% |
HPV11 | 0.25 | * | * | 22.3%** | Not tested |
HPV31 | 0.46 | * | * | * | 0.00% |
HPV33 | 1.64 | * | * | 0.14% | 0.01% |
HPV45 | 0.46 | * | *** | * | 0.02% |
HPV52 | 1.64 | * | 0.001% | 0.22% | 0.00% |
HPV58 | 1.14 | * | * | 1.90%** | 0.02% |